Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded
- Contract number
- SPE2DB26FX1LK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,176
Award facts
- Contract value 100% obligated
- $16,176.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $16,176.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 ml vials. This firm fixed-price delivery order, awarded on November 12, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, indicating the company competed on an unrestricted basis. The delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense medical supply operations.
DMS Pharmaceutical Group's PPV-G GEN V contract, valued at $499,999,999 and extending through December 31, 2036, positions the company as one of multiple regional prime vendor contractors authorized to supply a comprehensive range of pharmaceuticals, biologics, and medical consumables to military healthcare facilities worldwide. The company's established performance across numerous delivery orders spanning oncology treatments, immunosuppressants, vaccines, and routine pharmaceuticals demonstrates its capability to fulfill the specialized medical supply requirements of the federal military medical system. This delivery order for EYLEA HD represents routine pharmaceutical provisioning under the broader prime vendor framework supporting global Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FX1LK?
SPE2DB26FX1LK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FX1LK worth?
The government has obligated $16,176 on SPE2DB26FX1LK.
Is contract SPE2DB26FX1LK an order under another contract?
Yes. SPE2DB26FX1LK is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1LK competed?
The extent of competition for SPE2DB26FX1LK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award